A study, which appears in the Archives of Internal Medicine, has found knee replacement to be cost-effective for elderly patients, according to a report by the Wall Street Journal. According to the ...

Tirzepatide’s cost-effectiveness provides key evidence for policy makers implementing clinical coverage decisions. With Medicare drug coverage reviews approaching in the next few years, the higher ...

WASHINGTON - Knee replacement surgery is a safe and cost-effective treatment for persistent knee pain and disability, and increasing numbers of patients are seeking it at an earlier age, a panel of ...

Usual care provided 9.59 QALYs at a lifetime cost of $222,300, diet and exercise yielded 9.75 QALYs for $226,300, and semaglutide offered 10.48 QALYs at $273,500, with tirzepatide providing 10.68 ...